AGDA KARINA B. ETEROVIC to Imatinib Mesylate
This is a "connection" page, showing publications AGDA KARINA B. ETEROVIC has written about Imatinib Mesylate.
Connection Strength
0.029
-
Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma. J Invest Dermatol. 2019 03; 139(3):728-731.
Score: 0.029
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.